Unbalanced chromosome 1 abnormalities leading to partial trisomy 1q in four infants with Down syndrome and acute megakaryocytic leukemia

Molecular Cytogenetics

Volumn 2, Issue 1, 2009, Pages

  Silva, Maria Luiza MacEdo ^a   Do Socorro Pombo De Oliveira, Maria ^a   Raimondi, Susana C ^b   Mkrtchyan, Hasmik ^c   Abdelhay, Eliana ^a   De Figueiredo, Amanda Faria ^a   De Souza, Mariana Tavares ^a   Garcia, Daniela Ribeiro Ney ^a   De Ventura, Eliane Maria Soares ^d   De Sousa, Adriana Martins ^e   Liehr, Thomas ^c  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c Institute of Human Genetics and Anthropology   (Germany)

^d FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^e FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GLOBIN; IRON;

ACUTE MEGAKARYOCYTIC LEUKEMIA; CASE REPORT; CHROMOSOME 1Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME BANDING PATTERN; CHROMOSOME TRANSLOCATION 1; CHROMOSOME XP; DOWN SYNDROME; EXON; FEMALE; GENE; GENE MUTATION; HOSPITAL ADMISSION; HUMAN; INFANT; MALE; NOTE; PARTIAL TRISOMY; PRIORITY JOURNAL; PULMONARY ASPIRATION;

EID: 63449115797     PISSN: None     EISSN: 17558166     Source Type: Journal    
DOI: 10.1186/1755-8166-2-7     Document Type: Note

References (19)

1. Down myeloid disorders: a paradigm for childhood preleukaemia and leukaemia and insights into normal megakaryopoiesis. P Vyas I Roberts, Early Hum Dev 2006 82 767 773 10.1016/j.earlhumdev.2006.09.016 17064858
2. A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481. GV Massey A Zipursky MN Chang JJ Doyle S Nasim JW Taub Y Ravindranath G Dahl HJ Weinstein Children's Oncology Group (COG), Blood 2006 107 4606 4613 10.1182/blood-2005-06-2448 16469874
3. Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome. S Gurbuxani P Vyas JD Crispino, Blood 2004 103 399 406 10.1182/blood-2003-05-1556 14512321
4. Origins of leukaemia in children with Down syndrome. JK Hitzler A Zipursky, Nat Rev Cancer 2005 5 11 20 10.1038/nrc1525 15630411
5. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study. E Forestier S Izraeli B Beverloo O Haas A Pession K Michalová B Stark CJ Harrison A Teigler-Schlegel B Johansson, Blood 2008 111 1575 1583 10.1182/blood-2007-09- 114231 17971484
6. Natural history of GATA1 mutations in Down syndrome. M Ahmed A Sternberg G Hall A Thomas O Smith A O'Marcaigh R Wynn R Stevens M Addison D King B Stewart B Gibson I Roberts P Vyas, Blood 2004 103 2480 2489 10.1182/blood-2003-10-3383 14656875
7. The role of p53 in megakaryocyte differentiation and the megakaryocytic leukemias of Down syndrome. D Malkin EJ Brown A Zipursky, Cancer Genet Cytogenet 2000 116 1 5 10.1016/S0165-4608(99)00072-2 10616523
8. Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome. SE Holt EJ Brown A Zipursky, J Pediatr Hematol Oncol 2002 24 14 17 10.1097/00043426-200201000-00005 11902731
9. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. L Rainis D Bercovich S Strehl A Teigler-Schlegel B Stark J Trka N Amariglio A Biondi I Muler G Rechavi H Kempski OA Haas S Izraeli, Blood 2003 102 981 986 10.1182/blood-2002-11-3599 12649131
10. Trisomy 8 as a secondary genetic change in acute megakaryoblastic leukemia associated with Down's syndrome. SK Ma AC Lee TS Wan CK Lam LC Chan, Leukemia 1999 13 491 492 10.1038/sj/leu/2401330 10086746
11. BJ Bain, Leukemia diagnosis Blackwell Science, London 2 1999
12. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. H Hasle CM Niemeyer JM Chessells I Baumann JM Bennett G Kerndrup DR Head, Leukemia 2003 17 277 282 10.1038/sj.leu.2402765 12592323
13. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. JM Bennett D Catovsky MT Daniel G Flandrin DA Galton HR Gralnick C Sultan, Ann Intern Med 1985 103 460 462 2411180
14. Banding and molecular cytogenetic studies detected a CBFB-MYH11 fusion gene that appeared as abnormal chromosomes 1 and 16 in a baby with acute myeloid leukemia FAB M4-Eo. ML Macedo Silva SC Raimondi E Abdelhay M Gross H Mkrtchyan AF de Figueiredo RC Ribeiro T de Jesus Marques-Salles ES Sobral MP Gerardin Land T Liehr, Cancer Genet Cytogenet 2008 182 56 60 10.1016/j.cancergencyto.2007.12. 014 18328953
15. ISCN (2005): An International System for Human Cytogenetic Nomenclature. S. Karger, Basel, Shaffer LG, Tommerup N, 2005
16. Comparative M-FISH and CGH analyses in sensitive and drug-resistant human T-cell acute leukemia cell lines. A Weise T Liehr T Efferth A Kuechler E Gebhart, Cytogenet Genome Res 2002 98 118 125 10.1159/000069808 12697993
17. Multitude multicolor chromosome banding (mMCB) - a comprehensive one-step multicolor FISH banding method. A Weise A Heller H Starke K Mrasek A Kuechler BL Pool-Zobel U Claussen T Liehr, Cytogenet Genome Res 2003 103 34 39 10.1159/000076286 15004461
18. Microdissection based high resolution multicolor banding for all 24 human chromosomes. T Liehr A Heller H Starke N Rubtsov V Trifonov K Mrasek A Weise A Kuechler U Claussen, Int J Mol Med 2002 9 335 339 11891523
19. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). B Rigat C Hubert P Corvol F Soubrier, Nucleic Acids Res 1992 20 1433 1313972 10.1093/nar/20.6.1433-a